DHI
48
4
LH
43
-2
UPS
60
9
NEE
50
-5
ROP
62
3
AN
58
4
DG
6
2
SIG
52
3
ES
34
3
MSFT
50
3
LB
63
22
NAVI
52
5
FDX
43
3
CTSH
56
2
FSLR
54
7
NOC
43
11
RSG
71
3
TROW
56
5
YUM
47
3
AIV
72
2
DHI
48
4
LH
43
-2
UPS
60
9
NEE
50
-5
ROP
62
3
AN
58
4
DG
6
2
SIG
52
3
ES
34
3
MSFT
50
3
LB
63
22
NAVI
52
5
FDX
43
3
CTSH
56
2
FSLR
54
7
NOC
43
11
RSG
71
3
TROW
56
5
YUM
47
3
AIV
72
2
Financhill
Back

Verve Therapeutics Vs. Sage Therapeutics Industry Stock Comparison

Sell
25

VERV
Verve Therapeutics

Last Price:
4.85
Seasonality Move:
-11.16%
Sell
27

SAGE
Sage Therapeutics

Last Price:
5.15
Seasonality Move:
13.05%
Sell
25
Verve Therapeutics (VERV) is a Sell

Is Verve Therapeutics a Buy, Sell or Hold?

  • The current Verve Therapeutics [VERV] share price is $4.85. The Score for VERV is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • VERV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics a Buy, Sell or Hold?

  • The current Sage Therapeutics [SAGE] share price is $5.17. The Score for SAGE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VERV Stock Price Chart

What is Verve Therapeutics's stock price today?

  • The Verve Therapeutics share price today is $4.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing buying pressure, which is a positive indicator for future bullish movement.

SAGE Stock Price Chart

What is Sage Therapeutics's stock price today?

  • The Sage Therapeutics share price today is $5.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

VERV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 40.26 Sell
Chaikin Money Flow: 1039980 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.04 - 6.28) Sell
Bollinger Bands (100): (4.83 - 6.53) Sell

SAGE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 35.68 Sell
Chaikin Money Flow: 677330 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.14 - 7.48) Sell
Bollinger Bands (100): (6.13 - 10.09) Sell

VERV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.91 Sell
20-day SMA: 5.65 Sell
50-day SMA: 5.36 Sell
200-day SMA: 7.32 Sell
8-day EMA: 4.99 Sell
20-day EMA: 5.35 Sell
50-day EMA: 5.47 Sell
200-day EMA: 7.4 Sell

SAGE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.1 Buy
20-day SMA: 5.94 Sell
50-day SMA: 6.71 Sell
200-day SMA: 11.95 Sell
8-day EMA: 5.19 Sell
20-day EMA: 5.77 Sell
50-day EMA: 6.69 Sell
200-day EMA: 12.01 Sell

Verve Therapeutics Earnings Growth & VERV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.81 per share, and a decrease next year of $0.48 per share.

Sage Therapeutics Earnings Growth & SAGE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.06 per share, and an increase next year of $2.71 per share.

Verve Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sage Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):